Core Viewpoint - The report from GF Securities projects that China International Capital Corporation (CICC) will achieve a net profit attributable to shareholders of 8.13 billion CNY and 9.47 billion CNY for the years 2025 and 2026 respectively, with a target price of 28.43 HKD per share based on a 1x PB valuation for H-shares in 2026, maintaining a "Buy" rating for H-shares [1] Group 1 - In the short term, the integration plan supports stock price expectations, with the merger process releasing positive catalysts [1] - The review of the merger processes of four listed securities firms from 2023 to date indicates that the pricing scheme supports valuation relative to industry trends, with the merger of CICC marking the beginning of the integration of "Hui Jin" securities firms [1] Group 2 - In the medium to long term, the merger enhances CICC's capabilities to build a first-class investment bank through a strengthened client base and complementary regional networks [2] - The merger significantly boosts capital strength, improving net asset rankings to fourth in the industry and providing more flexibility in funding [2] - CICC's investment banking services extend the full-cycle value chain for corporate clients, enhancing competitiveness in managing non-performing assets and alternative investments [2]

中长期，1+1+1>3助力中金公司加速建设一流投行 短期来看，整合方案托底股价预期，合并流程释放利好催化 对2023年至今四家上市券商并购流程复盘，合并启动、股票复牌至第一次监管审核期间，定价方案托 底，整合与协同预期利好估值相对行业上行，后逐渐回归基本面定价。中金并购拉开"汇金系"券商整合 序幕，复牌后仍待交易所、证监会审核及董事会、股东大会审议未决事项。 智通财经APP获悉，广发证券发布研报称，预计中金公司(03908)2025-2026年归母净利润81.3/94.7亿 元，鉴于19-21年公司H股PB均值中枢为1.1倍，考虑景气度上行及公司加速整合释放协同效应，给予H 股2026年1倍PB估值，合理价值为28.43港元/股，维持H股"买入"评级。(HKD/CNY=0.93)(如无特别说 明，本报告货币单位为人民币) (1)客户基础壮大，区域网络互补。中金具备高质量客群基础、买方视角的财富管理服务体系、成功整 合经验。合并后，营业网点数量提升至行业第三，财富管理业务的规模效应与协同升级潜力显著。 广发证券主要观点如下： (2)资本实力显著增强，打开杠杆提升空间。合并后净资产排名提升至行业第四，净稳定资金率 ...

Company Overview - Ruipai Pet Hospital has submitted a listing application to the Hong Kong Stock Exchange, with China International Capital Corporation (CICC) as the sole sponsor [1] - Established in 2012, Ruipai is the first pet medical service provider in China to achieve nationwide chain operations [1] - As of June 30, 2025, Ruipai operates 548 pet hospitals, including 120 self-built and 428 acquired, making it the second-largest pet medical service provider in China [1] Business Model - Ruipai has pioneered the Veterinary Development Partners (VDP) model, aimed at uniting, motivating, and developing a high-level team of veterinarians in China [1] Industry Growth - The Chinese pet market is entering a phase of rapid growth, with the market size expected to increase from 300 billion yuan in 2024 to 1,113.9 billion yuan by 2035 [1] - The pet medical market is projected to grow from 36.6 billion yuan in 2024 to 139.2 billion yuan by 2035 [1] - High-tier cities dominate pet medical service consumption and institutional distribution, contributing 75.8% of the total revenue in the pet medical industry in 2024 [1]

平安证券指出，非银金融行业中，证券板块近期市场景气度改善、交投活跃度维持高位，板块从估 值到业绩均具备β属性，全面受益。长期看资本市场新一轮改革周期开启，券商仍有较大发展增量空 间。中金公司"三合一"重大资产重组预案出炉，合并后主体有望发挥原有中金公司投资银行、私募股权 投资、机构业务、资产管理和国际化业务优势，吸收信达证券和东方证券在企业纾困、并购重整、区域 布局、零售客户上的特色资源，实现汇金系"投行+AMC资源"的深度协同，加快一流投资银行和投资机 构建设进程。 证券ETF（512880）跟踪的是证券公司指数（399975），该指数从A股市场中选取涉及证券经纪、 投资银行、资产管理等业务的上市公司证券作为指数样本，以反映证券行业相关上市公司证券的整体表 现。证券公司指数覆盖了各类证券相关业务，具有较强的周期性和市场敏感性，是衡量资本市场活跃度 的重要指标之一。 风险提示：数据来源wind、截至2025.12.19，证券ETF规模为568.02亿，在同类21只产品中排名第 一。提及个股仅用于行业事件分析，不构成任何个股推荐或投资建议。指数等短期涨跌仅供参考，不代 表其未来表现，亦不构成对基金业绩的承诺或保 ...

Group 1: LPR and Monetary Policy - The last LPR quote for the year shows no change in both 1-year and 5-year rates, with only one interest rate cut in 2025 [1] - The Federal Reserve has cut rates three times this year, totaling a reduction of 75 basis points, contributing to the appreciation of the RMB against the USD [2][12] - This situation has reduced barriers for international capital flow into China and indicates significant monetary policy space for the upcoming year [13] Group 2: M&A Activity - China International Capital Corporation (CICC) is set to absorb and merge with both Xinda and Dongxing Securities [3][14] - The merger involves a complex share exchange where 1 share of Dongxing will convert to 0.4373 shares of CICC, and 1 share of Xinda will convert to 0.5188 shares of CICC [15] - Current share prices indicate a discrepancy, with Dongxing's implied post-merger price at 15.77 CNY and Xinda's at 18.71 CNY, while their actual prices are 14.21 CNY and 17.85 CNY, respectively, showing a price difference of 9.89% and 4.6% [6][15] Group 3: Market Dynamics and Strategies - The price difference arises from two factors: uncertainty regarding the execution of the merger and the time required for regulatory approvals [7][16] - If the merger is successful, the share prices of Xinda and Dongxing are expected to converge towards their implied merger prices as the execution date approaches [16] - Investors can consider strategies such as buying Xinda or Dongxing while shorting CICC to lock in the price difference, although this involves risks if the merger fails [7][16] Group 4: Cash Exit Options - Shareholders of Xinda and Dongxing have the option to choose cash instead of shares if they do not wish to become shareholders of CICC, which is a protective measure for shareholders [18] - The cash exit prices are set at 34.8 CNY for CICC, 17.79 CNY for Xinda, and 13.13 CNY for Dongxing, with hidden cash exit prices calculated based on the share exchange ratios [19] - Various strategies can be employed around these cash exit prices, including buying below the cash exit price and selling at the hidden cash exit price [19]

智通财经APP获悉，香港联交所最新资料显示，12月18日，China International Capital Corporation Limited增持纳芯微(02676)6.72万股，每股作价113.4707港元，总金额约为762.52万港元。增持后最新持 股数目约为367.03万股，最新持股比例为19.24%。 ...

Investment Rating - The report maintains a "Positive" investment rating for the non-bank financial sector [7]. Core Insights - The non-bank sector has shown strong performance this week, with notable developments in the brokerage sector, including the merger plans of China International Capital Corporation (CICC) with Dongxing and Xinda, indicating a further acceleration of supply-side reforms in the industry. The insurance sector is also seeing regulatory advancements with the China Banking and Insurance Regulatory Commission (CBIRC) seeking public opinion on the draft asset-liability management guidelines for insurance companies. The report suggests that the long-term outlook is positive, with improved return on equity (ROE) and valuation recovery expected, making the sector increasingly attractive for investment [2][4]. - The report recommends focusing on companies with stable profit growth and dividend rates, such as Jiangsu Jinzu, China Ping An, and China Pacific Insurance, which have strong market positions and business models. Additionally, it highlights companies like New China Life, China Life, Hong Kong Exchanges and Clearing, CITIC Securities, Dongfang Caifu, Tonghuashun, and Jiufang Zhitu Holdings based on their earnings elasticity and valuation levels [4]. Summary by Sections Market Performance - The non-bank financial index increased by 2.9% this week, outperforming the CSI 300 by 3.2%. Year-to-date, the non-bank financial index is up 9.8%, but underperformed the CSI 300 by 6.3% [5]. - The average daily trading volume in the market decreased to 17,604.84 billion yuan, down 9.86% week-on-week, with a daily turnover rate of 1.83%, down 19.91 basis points [5]. Industry News and Company Announcements - Key announcements include the merger plans of CICC with Dongxing and Xinda, and the CBIRC's public consultation on insurance asset-liability management guidelines. The report also notes the upcoming dividend announcements from Huaxi Securities, CICC, and Shenwan Hongyuan [6][19]. Insurance Sector Insights - In October 2025, the cumulative insurance premium income reached 548.33 billion yuan, a year-on-year increase of 7.99%. Life insurance premiums grew by 9.56%, while property insurance premiums increased by 4.02% [23][24]. - The total assets of insurance companies reached 40.59 trillion yuan, with life insurance companies holding 35.68 trillion yuan, reflecting a 0.68% increase [27][28]. Brokerage Sector Insights - The report highlights a decline in the overall equity market, with the CSI 300 index down 0.28% and the ChiNext index down 2.26%. The brokerage sector's investment assets are primarily in bonds, with equity investments comprising about 10%-30% [40][46]. - Margin trading balances decreased to 2.50 trillion yuan, down 0.34% week-on-week, indicating a cautious approach to stock pledge business due to previous credit risks [49]. Financing and Asset Management - In November 2025, equity financing reached 50.65 billion yuan, while bond financing totaled 706 billion yuan, indicating a recovery in financing activities [53]. - The report notes a rebound in the issuance of collective asset management products, with 4.387 billion units issued in November, up 4.1% from the previous month [55].

China International Capital Corporation Limited 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 承董事會命 中國國際金融股份有限公司 董事會秘書 孫男 中國，北京 2025年12月22日 中 國 國 際 金 融 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：03908） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列中國國際金融股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司2023 年面向專業投資者公開發行公司債券（第一期）（品種二）2026年票面利率調整及債券回售 實施的第一次提示性公告，僅供參閱。 於本公告日期，本公司執行董事為陳亮先生及王曙光先生；非執行董事為張薇女士、 孔令岩先生及田汀女士；以及獨立非執行董事為吳港平先生、陸正飛先生、彼得 • 諾蘭先 生及周禹先生。 债券代码:138842 债券简称:23 ...

中 國 國 際 金 融 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 China International Capital Corporation Limited 债券代码:175720 中国国际金融股份有限公司关于"21 中金 Y1" （股份代號：03908） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列中國國際金融股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司關於 「21中金Y1」提前贖回的第二次提示性公告，僅供參閱。 承董事會命 中國國際金融股份有限公司 董事會秘書 孫男 中國，北京 2025年12月22日 於本公告日期，本公司執行董事為陳亮先生及王曙光先生；非執行董事為張薇女士、 孔令岩先生及田汀女士；以及獨立非執行董事為吳港平先生、陸正飛先生、彼得 • 諾蘭先 生及周禹先生。 债券简称:21 中金Y1 提前赎回 ...

Core Viewpoint - The A-share market has shown a strong recovery, with the Shanghai Composite Index returning to 3900 points, indicating a bullish sentiment among investors and a potential for growth in the coming months [1][6]. Market Performance - On December 22, the Shanghai Composite Index closed at 3917.36 points, up 0.69%, while the Shenzhen Component Index rose 1.47% to 13332.73 points, and the ChiNext Index increased by 2.23% to 3191.98 points. The total trading volume in the Shanghai and Shenzhen markets reached 188.22 billion yuan, an increase of 133.5 billion yuan from the previous trading day [6]. - Major Asian markets also saw gains, with the Nikkei 225 index up 1.81% to 50402.39 points and the Korean Composite Index rising 2.12% to 4105.93 points [6]. Commodity Futures - On the same day, domestic commodity futures saw most contracts rise, particularly in the precious metals sector, with silver reaching a new high and both platinum and palladium hitting the daily limit [7]. Fund Flows - Data from Choice indicates that the top ten stocks with net inflows on December 22 included companies like Wolong Electric Drive, Zhongji Xuchuang, and Industrial Fulian, with several of these being CPO concept stocks [8]. Institutional Insights - According to a report from China International Capital Corporation (CICC), the recent adjustments in the market may be nearing an end, suggesting that the current liquidity environment remains relatively loose, providing a good opportunity for investors to position themselves for a year-end rally [9]. - Huatai Securities noted that the recent rebound in A-shares is primarily due to improved liquidity conditions, with significant net inflows from allocation-type funds. They anticipate a potential spring rally in 2024, although the market is currently navigating a period of uncertainty regarding fundamentals and policy [9]. - UBS Wealth Management's CIO office highlighted that AI innovation and related expenditures are expected to drive significant profit growth in China's technology sector by 2026, suggesting favorable liquidity and reasonable valuations could further support the Chinese stock market [9].